TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
CombiGene AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
5,544
|
26,699
|
84,042 |
Financial expenses |
5
|
2
|
0 |
Earnings before taxes |
-35,665
|
-6,157
|
20,965 |
EBITDA |
-35,976
|
-4,352
|
23,560 |
Total assets |
120,612
|
158,221
|
166,221 |
Current assets |
103,239
|
139,217
|
144,622 |
Current liabilities |
4,155
|
6,099
|
7,942 |
Equity capital |
116,457
|
152,122
|
158,279 |
- share capital |
990
![]() |
990
![]() |
990 |
Employees (average) |
8
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.6%
|
96.1%
|
95.2% |
Turnover per employee |
693
|
2,670
|
10,505 |
Profit as a percentage of turnover |
-643.3%
|
-23.1%
|
24.9% |
Return on assets (ROA) |
-29.6%
|
-3.9%
|
12.6% |
Current ratio |
2484.7%
|
2282.6%
|
1821.0% |
Return on equity (ROE) |
-30.6%
|
-4.0%
|
13.2% |
Change turnover |
-21,155
|
-57,343
|
84,042 |
Change turnover % |
-79%
|
-68% | |
Chg. No. of employees |
-2
|
2
|
4 |
Chg. No. of employees % |
-20%
|
25%
|
100% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.